Dr. David John Sinclair, MD

Dr. Sinclair practices at River Oaks Management Company in Byram, Mississippi.

Dr. Sinclair's NPI, 1235391046, was assigned on July 2, 2008. Dr. Sinclair holds Mississippi license 21995.

Dr. Sinclair's primary practice is River Oaks Management Company, at 7215 Siwell Rd, Byram, MS 39272 in Hinds County. The practice phone is (601) 376-1000.

Dr. Sinclair's primary practice is River Oaks Management Company in Byram, Mississippi. Dr. Sinclair is also affiliated with University of Mississippi Medical Center. The medical group on file is Merit Health Medical Group. Dmand AI also links Dr. Sinclair to 4 more hospitals, 3 medical groups and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Sinclair practices, 6 sites in all. Vendor and product names are available with a free account.

Clinical neurophysiology is Dr. Sinclair's primary specialty in the NPI Registry, under taxonomy code 2084N0600X. Dr. Sinclair is licensed in Mississippi.

CMS data shows 1,056 Medicare services from Dr. Sinclair across 19 procedure codes in 2024, for 421 Medicare patients. Medicare paid $81,308 for them.

CMS counts 421 Medicare patients who saw Dr. Sinclair in 2024. The largest group is 65 to 74, with 169 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 21% are also on Medicaid. Their average risk score is 1.74, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Sinclair's median patient age at 69, with 59% women.

In 2024, Dr. Sinclair wrote 2,997 Medicare Part D claims for 389 patients. 91% of them were for generic drugs. CMS names the drug for 2,618 of them, across 63 drugs with 11 or more claims each, at $435,317 in total drug cost. In 2023, CMS named 1,944 claims across 47 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Sinclair for performance year 2024, reported through an alternative payment model (APM). Dr. Sinclair accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 8 papers to Dr. Sinclair, published from 2011 to 2019. 2011 was the busiest year, with 2. The most frequent topics are Narcotic Antagonists. Dr. Sinclair has published most often in BMC Res Notes. Dr. Sinclair's most frequent co-author is Marie F. Grill, MD.

CMS Open Payments shows 346 general payments to Dr. Sinclair from 50 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 98% of the total. Eli Lilly and Company paid the most, $751.